Neuralink

Valuation $4B

About Neuralink

Neuralink develops a brain machine interface that provides solutions for those with paralysis.
Headquarters Neuralink, Fremont
Founded 2016-01-01
Industry Biotechnology, Medical, Neuroscience, Robotics
Last Funding Type Secondary Market
Valuation 4
Total Funding $686.24 million dollars
IPO Status Private

Financial

Neuralink was reported to be growing in Austin, indicating an increase in its operational presence. Additionally, the FDA approved Neuralink to proceed with a second brain implant, marking a significant milestone in its product development.
Neuralink is advancing brain-machine interfaces through various technologies. They are developing static and dynamic input multiplexing for high-density neural signal recording, which enhances the ability to process neural data. Their research includes wireless pairing systems for neural implants, allowing seamless communication between implanted and external devices. Additionally, they are working on neural signal compression techniques to efficiently manage data from brain-machine interfaces. These efforts highlight Neuralink's focus on improving neural data acquisition, processing, and communication for brain-machine interfaces.
Neuralink has encountered issues with its first human brain implant, including thread retraction and data loss. Despite these setbacks, the FDA has approved the implantation of a second patient. The company is actively seeking participants for further trials to evaluate and improve the device.
Funding Rounds 7
Number of Lead Investors 2
Total Funding Amount  $686.24 million dollars
Number of Investors 24

Related Angels

Fred Ehrsam
View profile
Sam Altman
View profile